IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis

Rui André Saraiva Raposo(George Washington University), Douglas F. Nixon(Cornell University)
JCI Insight
January 11, 2017
Cited by 13


Related Papers